Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.
about
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.Healthy Weight Loss for the Cancer SurvivorImpact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer.Physical activity, alcohol consumption, BMI and smoking status before and after prostate cancer diagnosis in the ProtecT trial: opportunities for lifestyle modification.CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment.Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population.Obesity, age, ethnicity, and clinical features of prostate cancer patients.Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping.A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment.The Effect of Nutrition Therapy and Exercise on Cancer-Related Fatigue and Quality of Life in Men with Prostate Cancer: A Systematic Review.Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.
P2860
Q27308897-31C01091-78D5-4E58-9180-D051D889EAD7Q30843223-EA2817CE-2116-43EC-87D3-AD8D842ADFA1Q35687599-63BFC69F-3712-465B-AA1D-A5D0F9B09601Q35985620-18F3A92B-1E92-4F3F-948F-F46B5CBCBA11Q36354580-BDB41D1C-CF2A-4F6C-A109-42F50526323BQ36974090-0BF61DE5-EC0D-4F6C-8DBB-207AFA8F62CEQ37665327-E12361F2-ED00-4F81-9E34-7461F688AF7CQ37692208-6E877EE7-52C7-4938-8C08-7D3EDFB37DD5Q38988252-2AE5F303-C18E-436D-82E5-224901C7C3C2Q39587790-1860EACC-7DE4-420E-A1F9-6569B48FBFBFQ41942897-063CFA4F-F186-4581-8CBA-8D9FFC6D5E93Q42021362-A7D44BD7-AACF-4633-BFFF-1EAE5BC901E2Q45046421-E4FDEC99-B944-4BB1-BDA1-C0AE68915DB3Q47758797-28A9C6BB-B3C6-4138-934B-8567308BF8B4Q52573392-9BB037CE-2F3F-498A-AA0E-6AF17917D257
P2860
Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Obesity is associated with ris ...... e cancers managed expectantly.
@en
Obesity is associated with ris ...... e cancers managed expectantly.
@nl
type
label
Obesity is associated with ris ...... e cancers managed expectantly.
@en
Obesity is associated with ris ...... e cancers managed expectantly.
@nl
prefLabel
Obesity is associated with ris ...... e cancers managed expectantly.
@en
Obesity is associated with ris ...... e cancers managed expectantly.
@nl
P2093
P1433
P1476
Obesity is associated with ris ...... e cancers managed expectantly.
@en
P2093
Alexandre R Zlotta
Andrew Evans
Antonio Finelli
Bimal Bhindi
Girish S Kulkarni
John Trachtenberg
Karen Hersey
Michael A S Jewett
Neil E Fleshner
P304
P356
10.1016/J.EURURO.2014.06.005
P407
P577
2014-06-18T00:00:00Z